Exam 9 Flashcards
Nucleoside Reverse Transcriptase Inhibitors
Zidovudine, Didanosine, Lamivudine, Emtricitabine, abacavir
Nucleotide Reverse Transcriptase Inhibitors
Tenofovir
Non-Nucleoside Reverse Transcriptase Inhibitors
Nevirapine, Efavirenz
Protease Inhibiors
Ritonavir, Indinavir sulfate, Nelfinavir mesylate, Lopinavir/Ritonavir, Atanavir sulfate
NRTI’s
- inhibit HIV reverse transcriptase
2. generally do not interact with other drugs or meals
Didanosine
NRTI that interacts with other drugs
Zidovudine-AZT
- NRTI (tx HIV)
- synthetic dideoxynucleoside (pyrimadine) antiviral
- thymidine analogue. can’t form phosphodiester linkages. lacks 3’ hydroxyl. leads to chain termination
- converted intracellularly to active triphosphate
- Plasma protein bound
- SE: anemia, neutropenia, bone marrow tox, granulocytopenia, CNS, GI
- CONTRAINDICATIONS: compromised bone marrow fxn
Combivir
lamivudine + zidovudine
Trizivir
lamivudine + zidovudine + abacavir
Drug that you do NOT give with Zidovudine
Stavudine. (antagonism)
Didanosine
- NTRI (tx HIV)
- Dideoxynucleoside (purine)
- inhibitor of reverse transcriptase by COMPETING with dATP for active site of enzyme
- converted to active triphosphate in cell
- lacks 3’ hydroxyl group. leads to chain termination
- absorption depends on food and pH
- SE: peripheral neuropathy, pancreatitis, GI
Zerit
DIdanosine + Zidovudine (or stavudine)
Lamivudine
- NTRI (tx HIV)
- carbon of ribose is replaced by sulfur
- less potent but LESS TOXIC
- competitive inhibition of reverse transcriptase
- ACTIVE AGAINST HEPATITIS B (flare ups if stop drug)
- resistance is rapidly developed (avoid monotherapy)
Epivir
Lamivudine
Epzicom
Abacavir + Lamivudine
Abacavir
- NRTI (tx HIV)
2. SE: SEVERE HSN RXN (rash, fever, malaise) + Resp and GI sx
Ziagen
Abacavir
Emtricitabine
- NRTI (tx HIV)
- derivative of Lamivudine
- BEST TOLERATED NRTI)
- SE: hyperpigmentation of palms and soles
- active against HEPATITIS B (can cause flare ups with drug withdrawl)
Emtriva
Emtricitabine
Truvada
fixed dose Emtricitabine + tenofovir
Atripla
efavirenz + tenofovir + emtricitabine
Tenofovir disoproxil
- NTRI (nucleotide)
- pro-drug of tenofovir
- effective against resistant HIV strains
- active against HEPATITIS B (flare up if discontinued)
- SE: N/V/D, renal tox
Nucleotides
phosphorylated nucleosides
Viread
tenofovir disoproxil
SIDE EFFECT OF ALL NNRTI’s
severe rash. metabolized by hepatic p450 enzymes
Nevirapine
- NNRTI (tx HIV)
- dipyridodiazepinone class
- binds directly to reverse transcriptase. blocks polymerase activity. disrupts enzyme’s catalytic site
- bound to plasma proteins, is a CSF concentration
- metabolized by cytochrome p450
- use in COMBO to prevent resistance
- SE: hepatotoxicity/failure/death (especially with underlying hepatitis or elevated transaminases), F/N/HA, early rash–>SJS
- use in combo with zidovudine/didanosine (nucleoside analogues)
Efavirenz
- NNRTI (tx HIV)
- long half-life. once daily dosing
- cytochrome p450
- plasma protein bound
- SE: Dizziness, HA, insomnia, rash
- CONSIDER: neural tube defects during first trimester of pregnancy
sustiva
efavirenz
protease inhibitor fxn
- prevent cleavage of protein precursors into individual functional proteins (required for maturation, infection and replication)
- inhibitors and metabolized by p45
- drug interactions are common
Ritonavir
- PI (tx HIV)
- enzyme then incapable of processing gal-pol polyprotein precursor. cannot infect.
- incomplete absorption and first pass-metabolism (by P450)
- highly bound to plasma proteins
- SE: N/V/D, CIRCUMORAL and PERIPHERAL PARESTHESIA, elevated liver enzymes
- used in combo with nucleoside analogues
Indinavir
- PI (tx HIV)
- binds to protease active site and inhibits enzyme
- incomplete absorption, first pass metabolism (p450)
- bound to plasma proteins (less than ritonavir)
- SE: NEPHROLITHIASIS (must drink lots of h20) hyperbilirubinemia, HA, vision change, dizziness, DERM CHANGES (alopecia, dry skin/mm)
- used in combo with nucleoside analogs
Indinavir + Ritonavir
cross resistance
Nelfinavir
- PI (tx HIV)
- highly plasma protein bound
- metabolism by p450
- SE: N/D
- MOST COMMONLY USED PROTEASE INHBITOR. GENERALLY TOLERATED
- used in combo with nucleoside analogs
Treatment Naive patients-HIV
- must have at lease three active antiretroviral meds that belong to different classes
Antiretroviral tx BACKBONE
2 nucleoside reverse transcriptase inhibitors (NRTIs)
Antiretroviral tx BASE
non-nucleoside reverse transcriptase inhibitor (NNRTI) OR protease inhibitor
NNRTI-based HIV treatment
1 NNRTI + 2 NRTIs
PI-based HIV treatment
1 or 2 PIs + 2 NRTIs
P. falciparum
malignant tartian malaria. most lethal. q3d.
P. vivax
benign tertian malaria. most common form. q3d. SECONDARY TISSUE FORMS
P. malariae
quartan malaria. q4d.
P. ovale
SECONDARY TISSUE FORMS
infectious form of malaria
sporozoite
malarial form that invades RBC
merozoite
Blood Schizonticides
“clinical cure”. suppress symptoms and do not affect secondary tissue forms
Tissue Shizonticides
do not suppress symptoms. know out secondary tissue forms of P. vivax and P. ovale. prevent relapse. higher toxicity
Clinical cure
erythrocytic forms of parasite have been eradicated. no symptoms.
Radical Cure
all forms of parasite have been eradicated
Gametocytocidal agents
act on gametocytes. slow the spread of the disease.
Causal prophylaxis
prevent initial development of primary hepatic forms. Primiquine, pyrimethamine and proguanil may have some activity.
Suppressive Agents
MOST COMMON PROPHYLACTIC AGENT. do not affect secondary tissue forms. do not prevent relapses.
Chloroquine
- Antimalarial
- acts on erythrocytic forms
- interferes with parasite’s feeding mechanisms.
- drug concentrates in and raises pH in parasite’s food vacuoles
- SUPPRESSIVE AGENT. leads to clinical cure. RADICAL CURE FOR FALCIP AND MALARIAE
- RESISTANCE: transport pump removes drug from parasite
- Accumulates in melanin-rich tissues-the skin and retina, concentrated in parasitized erythrocytes
- taken once weekly for prophylaxis
- TOXICITY: less than quinine.
- SE: GI, CNS, RETINAL AND CORNEAL TOX (must monitor visual fxn), LUPUS-LIKE
- CONTRAINDICATIONS: Pts with psoriasis and porphyria, liver disease pts.
hydroxychloroquine
- Antimalarial
- acts on erythrocytic forms
- interferes with parasite’s feeding mechanisms.
- drug concentrates in and raises pH in parasite’s food vacuoles
- SUPPRESSIVE AGENT. leads to clinical cure. RADICAL CURE FOR FALCIP AND MALARIAE
- RESISTANCE: transport pump removes drug from parasite
- Accumulates in melanin-rich tissues-the skin and retina, concentrated in parasitized erythrocytes
- taken once weekly for prophylaxis
- TOXICITY: less than quinine.
- SE: GI, CNS, RETINAL AND CORNEAL TOX (must monitor visual fxn), LUPUS-LIKE
- CONTRAINDICATIONS: Pts with psoriasis and porphyria, liver disease pts.
used to treat rheumatoid arthritis and lupus erythematosus
Hydroxychloroquine-anti-inflammatory at high doses
Quinine/Quinidine gluconate
- Antimalarial
- found in cinchona bark
- acts on erythrocytic forms
- GAMETOCYTOCIDAL (vivax and malariae)
- interference with plasmodial digestion of hemoglobin
- USED TO TREAT CHLOROQUINE RESISTANT FALCIPARUM
- SE: GI, N/V, tinnitus, deafness, CV: depressant on heart, birth defects, abortion
- CINCHONISM: quinine toxicity that resembles salicylism (HA, VISION, TINNITUS)
Chloroquine resistant P. Falciparum treatment
Quinine/Quinidine gluconate, mefloquine, pyrimethamine, proguanil
Drug that has analgesia and antipyretic actions like aspirin
quinine/quinidine gluconate
Drug used for nocturnal leg cramps
quinine/quinidine gluconate
Mefloquine
- antimalarial
- effective against chloroquine resistant falcip
- acts on erythrocytic forms of parasite (schizonticidal)
- “irritating properties” - can only be used orally
- less toxic than chloroquine. SE: GI upset and depression of myocardium.
- BUT: SEIZURES AND AGGRAVATION OF LATENT PSYCHOSES TOO.
- CONTRAINDICATIONS: CV disorders, Psychiatric problems, epilepsy.
Sulfonamides
- antimalarial.
- inhibit the incorporation of PABA into folic acid
- Sulfadoxine
Dihydrofolate reductase inhibitors
- antimalarial
- block conversion of dihydrofolic acid to tetrahydrofolic acid
- Pyrimethamine, proguanil
Pyrimethamine and Proguanil
- antimalarial
- inhibits dihydrofolate reductase. main effect on erythrocytic forms.
- Prophylatic use. chloroquine resistant falcip
- PROGUANIL HAS CAUSAL PROPHYLACTIC ACTIVITY
- Proguanil is relatively nontoxic. PyrMethamine: rash, bone marrow suppression
Pyrimethamine plus sulfadoxine
- used for presumptive treatment of malaria
- can be used in conjunction with artemisinin analogs for treatment of chloroquine resistant falcip
- Allergic rxn to sulfonamides
- Dihydrofolate and PABA block
Atovaquone plus proguanil
- newer antimalarial
- atovaquone: acts by depolarizing the parasite’s mitochondria and inhibiting electron transport
(proguanil=dihydrofolate reductase inhibitor) - SE: HA/Abdominal pain
- alternative to mefloquine or doxycycline for prophylaxis against chloroquine resistant falcip
- daily dosage
halofantrine
- new antimalarial
2. SE: GI
artemisinin
- Chinese herbal preparation
2. antimalarial
tetrandine
- antimalarial
2. against chloroquine resistant falcip
tetracycline ab (doxy)
- antimalarial activity
- used as alternate or adjunctive and prophylaxis
- Inhibition of protein synthesis
- Phototox, discoloration of teeth in children
- Contraindicated in children under 8 and pregnancy
Primaquine
- antimalarial
- Tissue schizonticide
- active against tissue forms of all species, gametocytocidal too
- little effect on erythrocytic forms (will not suppress disease after development)
- CAN PRODUCE A RADICAL CURE (in vivax and ovale)
- can also prevent initial development (causal) but is not used as prophylaxis due to toxicity
- SE: GI, CNS, HEMOLYTIC ANEMIA (in G6P Hydrogenase def.–>asians, afs, meds)
- TERATOGEN
Coartem
(artemether) artemisinin derivative in combo with lumafantrine (similar to halofantrine)
- VERY POPULAR TREATMENT FOR MOST FORMS Of MALARIA
- Given IM for lifethreatening falcip
- given in combo
treatment of pneumocystosis
primaquine plus clindamycin
G6P Hydrogenase deficiency
- resistance to malaria
2. asians, afs, meds
Order of useage for acute uncomplicated attack
- chloroquine (most sensitive forms)
- artemether/lumefantrine (all forms)
- quinine/quinidine gluconate (c resistant falcip)
- mefloquine (multidrug resistant falcip)
- atovaquone + proguanil (
- doxy (adjunct)
PREVENTION OF RELAPSE
primaquine
prophylaxis
- chloroquine
- atovaquone + proguanil
- doxy
- mefloquine
- proguanil/chlorquanide
- pyrimethanime + sulfadoxine–>presumptive tx
- primaquine–>flollow up tx
Mechlorethamine
- chemotherapeutic CCNS
- Alkylating agent. DNA damaging drug
- Nitrogen mustard
- TX: Hodgkin’s disease
- MOA: intramolecular cyclization to form ethyleneimonium ion–>directly or thru carbonic ion transfers alkyl group to cell
- Major site of alkylation in DNA is N7 (Guanine)
- Alkylation leads to: miscoidng of DNA, incomplete repair of segment, excessive crosslinking of DNA.
- Most susceptible to alkylation in LATE G1 AND S PHASES (but are not cell cycle specific)
- TOX: Vesicant at site of injection, bone marrow, spermatogenesis, GIT, hair follicles
- ACUTE: emesis, phlebitis. DELAYED: thrombocytopenia, immunosupression, secondary neoplasia
Cyclophosphamide
- chemotherapeutic CCNS
- alkylating agent. DNA damaging drug
- Nitrogen mustard
- derivative of mechlorethamine
- Requires metabolic activation by CYP450
- TX: leukemias, sex organ cancers, IMMUNOSUPPRESSIVE (organ transplant, wegener’s granuomatosis, RA)
- MOA: intramolecular cyclization to form ethyleneimonium ion–>directly or thru carbonic ion transfers alkyl group to cell
- Major site of alkylation in DNA is N7 (Guanine)
- Alkylation leads to: miscoidng of DNA, incomplete repair of segment, excessive crosslinking of DNA.
- Most susceptible to alkylation in LATE G1 AND S PHASES (but are not cell cycle specific)
- TOX: Vesicant at site of injection, bone marrow, spermatogenesis, GIT, hair follicles
- ACUTE: emesis, phlebitis. DELAYED: thrombocytopenia, immunosupression, secondary neoplasia
Carmustine
- chemotherapeutic CCNS
- nitrosourea
- alkylating agent/dna damaging (CCNS)
- requires activation
- lipid soluble
- TX: brain, lymphomas, myeloma
- bifunctional alkylator (2 Cl ions cleaved by hydrolysis, 2 sites for binding)
- phase nonspecific
- TOX: N/V, leukopenia, thrombocytopenia
Cisplatin
- chemotherapuetic CCNS
- platinum complex
- alkylating agent/dna damaging (CCNS)
- G1 may be most sensitive
- TX: sex organ CA, GI, lung, head
- bifunctional alkylating agent (2 Cl ions cleaved by hydrolysis, 2 sites for binding)
- inter/intrastrand crosslinking
- disrupts DNA double helix, interferes with DNA synthesis
- TOX: nephro and ototoxicity, bone marrow depression
Methotrexate
- chemotherapuetic CCS (S)
- antimetabolite (CCS/structural analogue)
- metabolized instead of normal substrate, incorporated, non-functional
- compete with normal metabolite at allosteric site on enzyme
- affect nucleotide/nucleic acid synthesis
- FOLIC ACID ANALOGUE. inhibitor of dihydrofolate reducatase. bloks conversion of folic acid to tetrahydrofolate. (inability to convert deoxyuridulate to thymidylate. blocks DNA, RNA, protein synth)
- poor CNS penetration
- highly bound to plasma proteins. displaced by salicylates
- can precipitate in renal tubules
- RESISTANCE: decreased uptake, increased concentration of target enzyme
- TX: leukemia, lymphomas, PSORIASIS, RA
- KILLS IN S PHASE
- TOX: ASCITES, EDEMA increase tox, N/V/D, GI, Oral ulcers, bone marrow suppresion, hepatotox, PULM INFILATRATES
Leucovirin
bypasses metabolic block by methotrexate and protects normal cells
Mercaptopurine
- chemotherapuetic CCS
- antimetabolite (CCS/structural analogue)
- metabolized instead of normal substrate, incorporated, non-functional
- compete with normal metabolite at allosteric site on enzyme
- affect nucleotide/nucleic acid synthesis
- PURINE ANALOG (of hypoxanthine)
- metabolized by xanthine oxidase–>6 thiouric acid
- TX: remission of leukemias
- MOA: converted by HGPRT. inhibits enzymes of purine conversion. INHIBIT PURINE NT SYNTH AND METABOLISM
- TOX: N/V/D, Bone marrow depression
Fluorouracil
- chemotherapuetic CCS
- antimetabolite cell cycle specific (CCS/structural analogue)
- metabolized instead of normal substrate, incorporated, non-functional
- compete with normal metabolite at allosteric site on enzyme
- affect nucleotide/nucleic acid synthesis
- PYRIMIDINE ANALOG
- converted to active 5-deoxyuridine
- TX: sex organ CA, GI, NECK
- 5-deoxyuridine binds to thymidylate synthetase. blocks conversion of deoxyuridylate to thymidylate (rate limiting step in DNA synthesis)
- Resistance: decreased activation, increased deactivation
- TOX: DONT CAUSE ACUTE TOX, delayed: GI ulceration, bone marrow depression
Cytarabine
- chemotherapuetic CCS
- antimetabolite- cell cycle specific (CCS/structural analogue)
- metabolized instead of normal substrate, incorporated, non-functional
- compete with normal metabolite at allosteric site on enzyme
- affect nucleotide/nucleic acid synthesis
- converted to Cytarabine triphosphate.
- TX: remission induction for leukemias
- inhibits DNA plyerase by competeing with substrate deoxycitidine triphosphate
- TOX: bone marrow depression, MEGALOBLASTOSIS, leukopenia, thrombocytopenia
Daunorubicin HCL
- Chemotherapeutic CCNS
- ‘natural product’ AB
- TX: acute non lymphocytic leukemia of adults
- GREATER ACTIVITY THAN DOXO
- intercalate adn bind to dNA between base pairs on adjacent strands…leads to uncoiling of DNA
- not CCS, but MAX EFFECT DURING S PHASSE
- Resistance: decreased uptake by tumors
- activity is dt tetracycline ring.
- different from DOXO by single hydroxyl group
- TOX: RED URINE, tissue necrosis, arrhytmias, BM depression, CARDIOMYOPATHY
Doxorubicin HCL
- chemotherapeutic CCNS
- ‘natural product’ AB
- TX: ADULT AND CHILD leukemias, CA of GU
- used in combo. synergy.
- intercalate adn bind to dNA between base pairs on adjacent strands…leads to uncoiling of DNA
- not CCS, but MAX EFFECT DURING S PHASSE
- Resistance: decreased uptake by tumors
- activity is dt tetracycline ring.
- different from DOXO by single hydroxyl group
- TOX: RED URINE, tissue necrosis, arrhytmias, BM depression, CARDIOMYOPATHY
Vinblastine Sulfate
- chemotherapeutic CCS (M)
- vinca alkaloid
- methyl group
- TX: Hodgkins, Kaposi’s, testicular, lung, bladder
- bind tubulin (microtubules) disruption of mitotic spindle. prevents segregation of chromosomes in METAPHASE
- TOX: mild N/V, phlebitis, DELAYED: neuro, bone marrow suppression
Vincristine Sulfate
- chemotherapuetic CCS (M)
- vinca alkaloid
- methyl group is replaced by formyl group from vinblastine
- TX: Breast, acute leukemia, H/N lymphoma
- bind tubulin (microtubules) disruption of mitotic spindle. prevents segregation of chromosomes in METAPHASE
- ACUTE TOX: local reactivity Delayed: neuro, alopecia
Etoposide
- chemotherapuetic CCS (G2)
- Natural product. epipodophylotoxin
- semisynthetic derivative of podophylootoxoin
- TX: testicular (plus belomycin and cisplatin), SSC of lung (plus cisplatin)
- forms complex with topoisomerase II and DNA. DNA breaks. cell death
- TOX: N/V/D with oral more so, leukopenia, alopecia
block action of xanthine oxidase
allopurinol
Paclitaxel
- chemotherapeutic CCS (G2/M)
- Natural product, taxene
- diterpene extracted from bark of “yew”
- TX: metastatic breast. ovarian, non SSC of lung
- MOA: antimicrotubule agent. promotes microtubule assembly, enhancing tubular polymerization
- TOX: N/V/D, bone marrow suppression, HSN, neuropathy, alopecia (IN ALMOST ALL PTS)
Prednisone
- chemotherapeutic
- hormonal agent
- adenocorticosteroid
- palliative management of leukemia and lymphoma in adults, acute leukemia of childhood, breast CA
- suppress mitosis in lymphocytes and macrophages
- binds to cytosolic receptors and affects DNA/RNA/Protein synth
- TOX: CUSHING’S SYNDROME, osteoporosis, infections, psych, peptic ulcers, HTN edema
Dexamethasone
- chemotherapeutic
- hormonal agent
- adenocorticosteroid
- palliative management of leukemia and lymphoma in adults, acute leukemia of childhood, breast CA
- suppress mitosis in lymphocytes and macrophages
- binds to cytosolic receptors and affects DNA/RNA/Protein synth
- TOX: CUSHING’S SYNDROME, osteoporosis, infections, psych, peptic ulcers, HTN edema
Tamoxifen
- chemotherapeutic CCS? (G1)
- nonsteroidal ANTIESTROGEN
- absorbed rapidly
- once daily administration
- extensive metabolism in the liver
- TX: estrogen + breast CA. adjuvent tx of breast CA (decreased recurrence and development of new ones). most frequently for breast cancer of MEN
- competitive inhibition of estrogen binding to receptors in sensitive tissues. Receptors are nuclear transription factors
- inhibits expression of estrogen related genes
- BLOCKS G1 PHASE OF CELL CYCLE
- works like estrogen in other tissues. decreased cholesterol, slows bone loss
- TOX: menopausal sx. ht flashes, HA, fatigue, vaginal dryness, visual disturbance, ocular tox THROMBOEMBOLIC EVENTS. POTENTIAL TUMOR PROMOTING ACTIVITY.
- increased incidence of endometrial CA
Imatinib Mesylate
- chemotherapeutic
- tyrosine kinase inhibitor
- well absorbed orally
- highly protein bound
- CYP3A4
- TX: leukemia, philadelphia chromosome + leukemia, GI stromal + cKit
- dermatofibrosarcoma, HYPEREOSINOPHILIC SYNDROME
- inhibits Bcr-Abl tyrosine kinase. prevents phosphorylation of kinase substrate by ATP
- induces apoptosis in bcr-abl leukemia in cell lines derived from pts with CML in blast crisis
- TOX: abdominal pain, N/V/D, fatigue, joint pain, muscle cramps, fluid retention, rash
Trastuzumab
- chemotherapeutic (CCS? G1)
- HUMANIZED IgG1 MoAB
- IV
- TX: EGR2 overexpressing CA (breast cancer) in combo with doxorubicin, cyclophosphamide, paclitaxel. Metastatic Breast CA: in combo with paclitaxel for 1st line of HER2-overexpressing
- MOA: binds to HUMAN EPDIERMAL GROWTH FACTER RECEPTOR (HER2). blocks binding. downregulates tyrosine kinase signaling activity.
- G1 CELL CYCLE ARREST
- TOX: N/V/D, anemia, neutropenia, infections, CARDIOMYOPATHY, INFUSION RXNS
Bcr-Abl fusion protein
constitutive abnormal tyrosine kinase created by t(9:22) philadelphia chromosomal translocation in CML
Chlorpromazine
- Antipsychotic
- phenothiazine
- first modern antipsychotic
- - - greater effect on positive sx
- neuroleptic effect
- effects slow over 2-4 w
- tolerance not an issue
- issue with compliance. effects seem unpleasant
- lowered seizure threshold
- ENTIEMETIC: desnsitization of CRTZ
- POIKILOTHERMIC: (less ability to control temp) effect on temp control center in hypothalamus
- ANTICHOLINERGIC: dry mouth, less accommodatoin, constipation, urine retention
- ANTIHISTAMINIC
- CV Effects: ortho hypotension (a-receptor antagonism), tachycardia, EKG changes, cardiac arrest, sudden death
- Inhibition of ejaculation
- Endocrine: increased prolactin (dt blockade of hypothalamic and pituitary dopamine receptors)–>gynecomastia, lactation, menstrual problems
- weight gain. stimulates appetite, fluid retention, affects insulin/glucose metabolism.
- AFFECTS SIMILAR TO T2DM
- inhibition of Ca calmodulin-dependent processes
- Teratogenesis
- INHIBITION OF DA RECEPTORS. in all systems (nigrostriatal, mesolimbic/mesocoritcla,tuberoinfundibular)
- drugs can interact with other receptors too. like muscarinic. serotonergic…Blocking 5HT2 effective against negative sx of schizo
- TOX: high margin of safety. allergic rxns, jaundice, rah, retinopathy, pigmentation of skin, CARDIOTOX,
- EXTRAPYRAMIDAL MOTOR SX. acute dystonia (grimacing, spasms), akathisia (need to be moving all time), parkinsonism, Neuroleptic malignant syndrome (stupor, rigidity, hyperthermia), Tardive dyskinesia
Fluphenazine
- Antipsychotic
- phenothiazine
- piperazine phenothiazine (SIMILAR TO TRIFLUOPERAZINE)
- long acting can be given depot injection q3-4w
- - - greater effect on positive sx
- neuroleptic effect
- effects slow over 2-4 w
- tolerance not an issue
- issue with compliance. effects seem unpleasant
- lowered seizure threshold
- ENTIEMETIC: desnsitization of CRTZ
- POIKILOTHERMIC: (less ability to control temp) effect on temp control center in hypothalamus
- ANTICHOLINERGIC: dry mouth, less accommodatoin, constipation, urine retention
- ANTIHISTAMINIC
- CV Effects: ortho hypotension (a-receptor antagonism), tachycardia, EKG changes, cardiac arrest, sudden death
- Inhibition of ejaculation
- Endocrine: increased prolactin (dt blockade of hypothalamic and pituitary dopamine receptors)–>gynecomastia, lactation, menstrual problems
- weight gain. stimulates appetite, fluid retention, affects insulin/glucose metabolism.
- AFFECTS SIMILAR TO T2DM
- inhibition of Ca calmodulin-dependent processes
- Teratogenesis
- INHIBITION OF DA RECEPTORS. in all systems (nigrostriatal, mesolimbic/mesocoritcla,tuberoinfundibular)
- drugs can interact with other receptors too. like muscarinic. serotonergic…Blocking 5HT2 effective against negative sx of schizo
- TOX: high margin of safety. allergic rxns, jaundice, rah, retinopathy, pigmentation of skin, CARDIOTOX,
- EXTRAPYRAMIDAL MOTOR SX. acute dystonia (grimacing, spasms), akathisia (need to be moving all time), parkinsonism, Neuroleptic malignant syndrome (stupor, rigidity, hyperthermia), Tardive dyskinesia
Prochlorperazine
- Antipsychotic
- phenothiazine
- aliphatic phenothiazine (SIMILAR TO TRIFLUOPERAZINE)
- COMMONLY USED AS ANTIEMETIC
- - - greater effect on positive sx
- neuroleptic effect
- effects slow over 2-4 w
- tolerance not an issue
- issue with compliance. effects seem unpleasant
- lowered seizure threshold
- ENTIEMETIC: desnsitization of CRTZ
- POIKILOTHERMIC: (less ability to control temp) effect on temp control center in hypothalamus
- ANTICHOLINERGIC: dry mouth, less accommodatoin, constipation, urine retention
- ANTIHISTAMINIC
- CV Effects: ortho hypotension (a-receptor antagonism), tachycardia, EKG changes, cardiac arrest, sudden death
- Inhibition of ejaculation
- Endocrine: increased prolactin (dt blockade of hypothalamic and pituitary dopamine receptors)–>gynecomastia, lactation, menstrual problems
- weight gain. stimulates appetite, fluid retention, affects insulin/glucose metabolism.
- AFFECTS SIMILAR TO T2DM
- inhibition of Ca calmodulin-dependent processes
- Teratogenesis
- INHIBITION OF DA RECEPTORS. in all systems (nigrostriatal, mesolimbic/mesocoritcla,tuberoinfundibular)
- drugs can interact with other receptors too. like muscarinic. serotonergic…Blocking 5HT2 effective against negative sx of schizo
- TOX: high margin of safety. allergic rxns, jaundice, rah, retinopathy, pigmentation of skin, CARDIOTOX,
- EXTRAPYRAMIDAL MOTOR SX. acute dystonia (grimacing, spasms), akathisia (need to be moving all time), parkinsonism, Neuroleptic malignant syndrome (stupor, rigidity, hyperthermia), Tardive dyskinesia